Thus, immunosuppressive tumor cytokines and AhR stimulation promote CD83 downregulation and generation of CD83- IDO1+LCs (immature tolerogenic LCs) and/or CD83- IDO1-LCs (real immature LCs). The gene discussed is AHR; the disease is neoplasm.